Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 1/2 1

Status

Completed 27Recruiting 20Terminated 10Withdrawn 6Active not recruiting 6Unknown 5Not yet recruiting 3

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Recurrence 13Multiple Myeloma 12Lymphoma, B-Cell 12Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Ovarian Neoplasms 7Burkitt Lymphoma 7Lymphoma 6Lymphoma, Mantle-Cell 5Hematologic Neoplasms 5Nasopharyngeal Carcinoma 4Myelodysplastic Syndromes 4Melanoma 4Lymphoma, T-Cell 4Leukemia 3Graft vs Host Disease 3Uterine Cervical Neoplasms 2Sarcoma, Synovial 2Neuroblastoma 2Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, T-Cell 2Hodgkin Disease 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Cyclophosphamide 6fludarabine 5Exercise 4Blood Specimen Collection 4Immunotherapy, Adoptive 3thymoglobulin 2pegylated granulocyte colony-stimulating factor 2Voriconazole 2Surveys and Questionnaires 2Stem Cell Transplantation 2Physical Therapy Modalities 2Parenteral Nutrition 2Etoposide 2Cytarabine 2CF regimen 2BNT162 Vaccine 2Azacitidine 2venetoclax 1trihexyltetradecylphosphonium chloride 1treosulfan 1shengxuening 1ruxolitinib 1ramosetron 1monalizumab 1glucarpidase 1fludarabine phosphate 1ferrous succinate 1eltrombopag 1dexamethasone 21-phosphate 1Whole-Body Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Hematologic Neoplasms × fludarabine × Clear all
NCT05084027 2021-10-27

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

First Affiliated Hospital of Zhejiang University

Phase 2 Unknown
50 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03110640 2019-11-27

Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma

First Affiliated Hospital of Wenzhou Medical University

Phase 1 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT03344705 2017-11-17

Safety and Efficacy Evaluation of IM19 Cells

Beijing Immunochina Medical Science & Technology Co., Ltd.

Phase 1 Unknown
20 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02685670 2017-03-16

MatchCART

The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine

Phase 1/2 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT00750126 2011-01-19

RICE

University Hospital, Clermont-Ferrand

Phase 2 Unknown
30 enrolled
Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡